Seven years after the UK legalised cannabis-based products for medicinal use (CBPMs), the numbers are no longer incremental. Between 2022 and 2024, the total…
Read More
Poland: Europe’s Quiet Cannabis Giant with 105,000 Patients and 5 Tonnes Dispensed in 2025
When most analysts discuss European cannabis, the conversation defaults to Germany’s scale, the UK’s private clinics, or the Czech Republic’s new adult-use…
Read More
Canada Exports 240 Tonnes of Cannabis in 2025: Where It’s Going and Why It Doubled
Canadian cannabis producers shipped an estimated 240 tonnes of medical cannabis to international markets in 2025, more than doubling the 107 tonnes exported in…
Read More
Australia’s Billion-Dollar Cannabis Milestone: 41 Cultivators, 41 Tonnes, and a Market That Won’t Stop Growing
Australia’s medical cannabis market crossed the AUD $1 billion mark in 2025. That single figure captures a transformation that has unfolded with remarkable…
Read More
Brazil’s ANVISA Publishes 5 New Cannabis Resolutions: What RDC 1,012 to 1,015 Mean for the Industry
Brazil’s ANVISA voted on January 28, 2026 to approve five new cannabis resolutions–RDC 1,011 through RDC 1,015–marking the most significant regulatory shift in the country’s medical cannabis market since 2019. Here’s what each resolution means for producers and operators.
Read More
VAC Cuts Medical Cannabis Reimbursement Cap from $8.50/g to $6.00/g, Effective April 1
Veterans Affairs Canada reduces the medical cannabis reimbursement cap from $8.50/g to $6.00/g effective April 1, 2026. What LPs need to know and do now.
Read More